Francesca Mattioli

Dr. Francesca Mattioli

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
FMFrancesca Mattioli
Francesca Mattioli
HDHossein Darvish
Hossein Darvish
SPSohail Aziz Paracha
Sohail Aziz Paracha
ATAbbas Tafakhori
Abbas Tafakhori
SFSaghar Ghasemi Firouzabadi
Saghar Ghasemi Firouzabadi
MAMuhammad Ansar
Muhammad Ansar
Intellectual disability (ID) is a highly heterogeneous disorder with hundreds of associated genes. Despite progress in the identification of the genetic causes of ID following the introduction of high-throughput sequencing, about half of affected individuals still remain without a molecular diagnosis. Consanguineous families with affected individuals provide a unique opportunity to identify novel recessive causative genes. In this report, we describe a novel autosomal recessive neurodevelopmental disorder. We identified two consanguineous families with homozygous variants predicted to alter the splicing of ATP9A which encodes a transmembrane lipid flippase of the class II P4-ATPases. The three individuals homozygous for these putatively truncating variants presented with severe ID, motor and speech impairment, and behavioral anomalies. Consistent with a causative role of ATP9A in these patients, a previously described Atp9a−/− mouse model showed behavioral changes.

21 May 2023 in Genetics in Medicine
Verified
Journal Article
Open access
FMFrancesca Mattioli
Francesca Mattioli
LWLina Worpenberg
Lina Worpenberg
CLCai-Tao Li
Cai-Tao Li
NINazia Ibrahim
Nazia Ibrahim
SNShagufta Naz
Shagufta Naz
ARAlexandre Reymond
Alexandre Reymond
5-methylcytosine RNA modifications are driven by NSUN methyltransferases. Although variants in NSUN2 and NSUN3 were associated with neurodevelopmental diseases, the physiological role of NSUN6 modifications on transfer RNAs and messenger RNAs remained elusive. We combined exome sequencing of consanguineous families with functional characterization to identify a new neurodevelopmental disorder gene. We identified 3 unrelated consanguineous families with deleterious homozygous variants in NSUN6. Two of these variants are predicted to be loss-of-function. One maps to the first exon and is predicted to lead to the absence of NSUN6 via nonsense-mediated decay, whereas we showed that the other maps to the last exon and encodes a protein that does not fold correctly. Likewise, we demonstrated that the missense variant identified in the third family has lost its enzymatic activity and is unable to bind the methyl donor S-adenosyl-L-methionine. The affected individuals present with developmental delay, intellectual disability, motor delay, and behavioral anomalies. Homozygous ablation of the NSUN6 ortholog in Drosophila led to locomotion and learning impairment. Our data provide evidence that biallelic pathogenic variants in NSUN6 cause one form of autosomal recessive intellectual disability, establishing another link between RNA modification and cognition.

13 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
NINazia Ibrahim
Nazia Ibrahim
SNShagufta Naz
Shagufta Naz
FMFrancesca Mattioli
Francesca Mattioli
NGNicolas Guex
Nicolas Guex
SSSaima Sharif
Saima Sharif
ARAlexandre Reymond
Alexandre Reymond
GEMIN5 is a multifunctional RNA-binding protein required for the assembly of survival motor neurons. Several bi-allelic truncating and missense variants in this gene are reported to cause a neurodevelopmental disorder characterized by cerebellar atrophy, intellectual disability (ID), and motor dysfunction. Whole exome sequencing of a Pakistani consanguineous family with three brothers affected by ID, cerebral atrophy, mobility, and speech impairment revealed a novel homozygous 3bp-deletion NM_015465.5:c.3162_3164del that leads to the loss of NM_015465.5 (NP_056280.2):p. (Asp1054_Ala1055delinsGlu) amino acid in one of the α-helixes of the tetratricopeptide repeats of GEMIN5. In silico 3D representations of the GEMIN5 dimerization domain show that this variant likely affects the orientation of the downstream sidechains out of the helix axis, which would affect the packing with neighboring helices. The phenotype of all affected siblings overlaps well with previously reported patients, suggesting that NM_015465.5: c.3162_3164del (NP_056280.2):p. (Asp1054_Ala1055delinsGlu) is a novel GEMIN5 pathogenic variant. Overall, our data expands the molecular and clinical phenotype of the recently described neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) syndrome.

2 February 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
FMFrancesca Mattioli
Francesca Mattioli
NVNorine Voisin
Norine Voisin
EPEglė Preikšaitienė
Eglė Preikšaitienė
IKIrina Kozlovskaja
Irina Kozlovskaja
VKVaidutis Kučinskas
Vaidutis Kučinskas
ARAlexandre Reymond
Alexandre Reymond

12 December 2024 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
CSCosima M. Schmid
Cosima M. Schmid
AGAnne Gregor
Anne Gregor
ARAnna Ruiz
Anna Ruiz
CBCarmen Manso Bazús
Carmen Manso Bazús
IHIsabella Herman
Isabella Herman
CZChristiane Zweier
Christiane Zweier
While mostly de novo truncating variants in SCAF4 were recently identified in 18 individuals with variable neurodevelopmental phenotypes, knowledge on the molecular and clinical spectrum is still limited. We assembled data on 50 novel individuals with SCAF4 variants ascertained via GeneMatcher and personal communication. With detailed evaluation of clinical data, in silico predictions and structural modeling, we further characterized the molecular and clinical spectrum of the autosomal dominant SCAF4-associated neurodevelopmental disorder. The molecular spectrum comprises 25 truncating, eight splice-site and five missense variants. While all other truncating variants were classified as pathogenic/likely pathogenic, significance of one C-terminal truncating variant, one splice-site variant and the missense variants remained unclear. Three missense variants in the CTD-interacting domain of SCAF4 were predicted to destabilize the domain. Twenty-three variants occurred de novo, and variants were inherited in 13 cases. Frequent clinical findings were mild developmental delay with speech impairment, seizures, and skeletal abnormalities such as clubfoot, scoliosis or hip dysplasia. Cognitive abilities ranged from normal IQ to severe intellectual disability (ID), with borderline to mild ID in the majority of individuals. Our study confirms the role of SCAF4 variants in neurodevelopmental disorders and further delineates the associated clinical phenotype.

4 June 2021 in medRxiv
Verified
Preprint
Open access
PDF file
FMFrancesca Mattioli
Francesca Mattioli
HDHossein Darvish
Hossein Darvish
SPSohail Aziz Paracha
Sohail Aziz Paracha
ATAbbas Tafakhori
Abbas Tafakhori
SFSaghar Ghasemi Firouzabadi
Saghar Ghasemi Firouzabadi
MAMuhammad Ansar
Muhammad Ansar
Intellectual disability (ID) is a highly heterogeneous disorder with hundreds of associated genes. Despite progress in the identification of the genetic causes of ID following the introduction of high-throughput sequencing, about half of affected individuals still remain without a molecular diagnosis. Consanguineous families with affected individuals provide a unique opportunity to identify novel recessive causative genes. In this report we describe a novel autosomal recessive neurodevelopmental disorder. We identified two consanguineous families with homozygous variants predicted to alter the splicing of ATP9A which encodes a transmembrane lipid flippase of the class II P4-ATPases. The three individuals homozygous for these putatively truncating variants presented with severe ID, motor and speech impairment, and behavioral anomalies. Consistent with a causative role of ATP9A in these patients, a previously described Atp9a-/- mouse model showed behavioral changes.